Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites

For patients with cirrhosis, no definitive predictor of the efficacy and prognosis of tolvaptan treatment exists. We assessed the cisterna chyli’s utility as an optimal marker. We retrospectively enrolled 172 patients with cirrhosis. The effect of tolvaptan was evaluated using post-treatment surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirooka, Masashi, Koizumi, Yohei, Yano, Ryo, Nakamura, Yoshiko, Sunago, Koutarou, Yukimoto, Atsushi, Watanabe, Takao, Yoshida, Osamu, Tokumoto, Yoshio, Abe, Masanori, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114325/
https://www.ncbi.nlm.nih.gov/pubmed/35581243
http://dx.doi.org/10.1038/s41598-022-11889-z

Ejemplares similares

Ejemplares similares